| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $7.81 ▼ -0.80% | Yesterday | $7.90 ▲ +0.33% | Tomorrow's Gyre Therapeutics Inc. Common Stock (GYRE) setup is anchored to $7.87 and targets $7.81 (-0.80%). The near-term read is downside; watch $8.11 / $7.63 because daily realized volatility is about 4.10%. |
Tomorrow's Gyre Therapeutics Inc. Common Stock (GYRE) setup is anchored to $7.87 and targets $7.81 (-0.80%). The near-term read is downside; watch $8.11 / $7.63 because daily realized volatility is about 4.10%. | ||||
| Week | $7.68 ▼ -2.48% | Last Week | $7.95 ▲ +1.04% | The 7-day Gyre Therapeutics Inc. Common Stock model moves from $7.95 to $7.68 (-2.48%). It gives downside momentum context for this stock, so breaks around $8.11 / $7.63 matter more than a single tick. |
The 7-day Gyre Therapeutics Inc. Common Stock model moves from $7.95 to $7.68 (-2.48%). It gives downside momentum context for this stock, so breaks around $8.11 / $7.63 matter more than a single tick. | ||||
| Month | $7.46 ▼ -5.27% | Last Month | $8.04 ▲ +2.21% | The 1-month Gyre Therapeutics Inc. Common Stock target is $7.46 (-5.27%), compared with the live reference near $7.87. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Gyre Therapeutics Inc. Common Stock target is $7.46 (-5.27%), compared with the live reference near $7.87. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $7.13 ▼ -9.46% | Last Year | $8.18 ▲ +3.97% | The 1-year Gyre Therapeutics Inc. Common Stock scenario points to $7.13 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Gyre Therapeutics Inc. Common Stock scenario points to $7.13 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $6.35 ▼ -19.29% | 5 Years Ago | $8.51 ▲ +8.10% | The 5-year Gyre Therapeutics Inc. Common Stock view is $6.35 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Gyre Therapeutics Inc. Common Stock view is $6.35 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $7.87 | Mid |
| Daily Change | -0.88% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $7.87 | Daily Change | -0.88% |
| Market Cap | $763.34M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.